0000899243-22-025708.txt : 20220707
0000899243-22-025708.hdr.sgml : 20220707
20220707162540
ACCESSION NUMBER: 0000899243-22-025708
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220705
FILED AS OF DATE: 20220707
DATE AS OF CHANGE: 20220707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLD DANIEL P PHD
CENTRAL INDEX KEY: 0001288233
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50484
FILM NUMBER: 221071910
MAIL ADDRESS:
STREET 1: 10445 PACIFIC CENTER CT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEI Pharma, Inc.
CENTRAL INDEX KEY: 0001262104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510407811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-369-7100
MAIL ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MARSHALL EDWARDS INC
DATE OF NAME CHANGE: 20030902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-05
0
0001262104
MEI Pharma, Inc.
MEIP
0001288233
GOLD DANIEL P PHD
C/O MEI PHARMA, INC.
11455 EL CAMINO REAL, SUITE 250
SAN DIEGO
CA
92130
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
0.54
2022-07-05
4
A
0
1496000
0.00
A
2032-07-05
Common Stock
1496000
1496000
D
Stock Option (Right to Buy)
2.95
2031-07-01
Common Stock
855000
855000
D
Stock Option (Right to Buy)
1.57
2025-07-28
Common Stock
275500
275500
D
Stock Option (Right to Buy)
1.36
2026-07-29
Common Stock
380000
380000
D
Stock Option (Right to Buy)
2.83
2027-07-06
Common Stock
380000
380000
D
Stock Option (Right to Buy)
4.33
2028-06-22
Common Stock
380000
380000
D
Stock Option (Right to Buy)
4.28
2028-07-12
Common Stock
300000
300000
D
Stock Option (Right to Buy)
2.52
2029-07-01
Common Stock
675000
675000
D
Stock Option (Right to Buy)
3.49
2030-07-02
Common Stock
680000
680000
D
One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023.
One-quarter of such options vested on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
All of such options are presently exercisable.
One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.
/s/ Brian G. Drazba, as attorney in fact
2022-07-07